humulin 30/70
eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] (as 70% isophane insulin and 30% regular insulin) excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus
insulin human winthrop
sanofi-aventis deutschland gmbh - insulin human - diabetes mellitus - drugs used in diabetes - diabetes mellitus where treatment with insulin is required. insulin human winthrop rapid is also suitable for the treatment of hyperglycaemic coma and ketoacidosis, as well as for achieving pre-, intra- and postoperative stabilisation in patients with diabetes mellitus.
wosulin-30/70 100iu/ml
ambica international corp.; distributor: gx laboratories, inc. - biphasic isophane insulin human (recombinant dna origin) - suspension for injection (sc) (30% regular insulin human/70% isophane insulin human) - 100iu/ml
glysolin 30/70 100iu/ml
ambica international corp.; distributor: the cathay yss distributors co., ltd. - biphasic isophane insulin human (recombinant dna origin) - suspension for injection (sc) (30% regular insulin human/70% isophane insulin human) - 100iu/ml
humulin nph
eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - suspension for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: dibasic sodium phosphate heptahydrate glycerol hydrochloric acid as 10% solution for ph adjustment metacresol phenol protamine sulfate sodium hydroxide as 10% solution for ph adjustment water for injection zinc oxide - humulin is indicated for the treatment of insulin-requiring diabetes mellitus
humulin r
eli lilly and company (nz) limited - insulin, human, recombinant dna origin 100 [iu] - solution for injection - 100 iu/ml - active: insulin, human, recombinant dna origin 100 [iu] excipient: glycerol hydrochloric acid as 10% solution for ph adjustment metacresol sodium hydroxide as 10% solution for ph adjustment water for injection - humulin is indicated for the treatment of insulin-requiring diabetes mellitus.
mixtard 30
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 70 iu/ml; ; neutral insulin, human, pyr 30 iu/ml; - suspension for injection - active: isophane insulin, human, pyr 70 iu/ml neutral insulin, human, pyr 30 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc - treatment of diabetes mellitus.
penmix 30 penfill
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 70 iu/ml; ; neutral insulin, human, pyr 30 iu/ml; - suspension for injection - active: isophane insulin, human, pyr 70 iu/ml neutral insulin, human, pyr 30 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc as chloride, approx - treatment of diabetes mellitus.
protaphane
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 100 iu/ml; - suspension for injection - 100 iu/ml - active: isophane insulin, human, pyr 100 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc - treatment of diabetes mellitus.
protaphane penfill
novo nordisk pharmaceuticals ltd - isophane insulin, human, pyr 100 iu/ml; - suspension for injection - 100 iu/ml - active: isophane insulin, human, pyr 100 iu/ml excipient: dibasic sodium phosphate dihydrate glycerol hydrochloric acid metacresol phenol protamine sulfate sodium hydroxide water for injection zinc - treatment of diabetes mellitus.